Country - Estonia
Summary - Buying Bevacizumab, Nab-Paclitaxel, And Tocilizumab
Deadline - login to view
MT reference number - 99880383
Product classification - Pharmaceutical products
Address - Estonia
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 99880383
Document Type - Tender Notices
Description - Description: The object of the procurement is biological medicines with the active ingredients bevacizumab, nab-paclitaxel and tocilizumab. The Health Insurance Fund is participating in the procurement together with the HVA hospitals.local title:: Be vatsizumabi, nab-paklitakseeli ja totsilizumabi ostmineContract Type: : Supplylocal description: : Hanke objektiks on bioloogilised ravimid toimeainetega bevatsizumab, nab-paklitakseel ja totsilizumab. Hankes osaleb Tervisekassa koos HVA haiglatega. dispatch_date: 2024-12-12 00:00:00 lot_details: 1: Bevacizumab, concentrate for solution for infusion biosimilar or biooriginal 400mg, 2: Bevatsizumab, infusion solution concentrate bio-original 100mg
Mt Ref Id - 99880383
Deadline - Nov 30, -0001
Similar Tenders :
Healthcare and Medicine